A Couples-based Approach for Increasing Physical Activity Among Adults With Type 2 Diabetes

March 19, 2018 updated by: University of Colorado, Denver

In a 6-week experimental design, up to 90 adult couples in which one partner has Type 2 Diabetes (T2D) will be randomly assigned to either the collaborative implementation intentions (Collaborative IIs), the Individual Implementation Intentions (Individual IIs) condition, or the control condition. As this is a pilot study, randomization for the experimental groups vs the control groups will occur at a 2:1 ratio. Thus, the experimental conditions will contain up to 36 participants and the control condition will contain up to 18 participants. Adults with T2D who are living with a romantic partner, not meeting current physical activity guidelines but able and willing to begin a new physical activity (PA) routine and their partners will be assessed at baseline, 3 weeks and 6 weeks after the experimental manipulation. Partners will report on their own investment in the patient's goal and patients will report on their own PA self-efficacy. Patient's PA will be measured through self-report, partner report and accelerometers for a week prior to each survey assessment. These specific aims are planned:

AIM 1: Determine whether collaborative IIs for patient's PA lead to a greater increase in partner investment in partners of adults with T2D than do individual IIs or control.

AIM 2: Determine whether collaborative IIs for patient's PA lead to a greater increase in patient PA self-efficacy in adults with T2D than do individual IIs or control.

AIM 3: Determine whether collaborative IIs for patient's PA lead to a greater increase in patient PA in adults with T2D than do individual IIs or control.

Study Overview

Study Type

Interventional

Enrollment (Actual)

80

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Colorado
      • Denver, Colorado, United States, 80204
        • University of Colorado Denver

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

21 years to 69 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • At least 21 years of age
  • Able to read and understand English
  • Does not meet physical activity guidelines (< 150 minutes of moderate-vigorous exercise per week) for the last 3 months* (only required of one partner)
  • Diagnosed with Type 2 Diabetes* (only required of one partner)
  • Married or living with a romantic partner

Exclusion Criteria:

  • Medical or physical contraindications to participate in physical activity

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: With spouse/romantic partner
With spouse/romantic partner
EXPERIMENTAL: Without spouse/romantic partner
Without spouse/romantic partner
OTHER: Control
No Intervention

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Self-Reported Physical Activity via IPAQ
Time Frame: Baseline, 3 weeks, 6 weeks
Participants will self-report their physical activity over the past week using the International Physical Activity Questionnaire (IPAQ)
Baseline, 3 weeks, 6 weeks
Objective Physical Activity via accelerometer
Time Frame: Basline, 6 weeks
Participants will wear Actigraph Accelerometers
Basline, 6 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Physical Activity Self-Efficacy via a self efficacy scale
Time Frame: Baseline, 3 weeks, 6 weeks
Physical activity self-efficacy will be measured using the self-efficacy for exercise scale (SEE; Resnick & Jenkins, 2000). This 9-item, self-report scale assesses participant's confidence that they could exercise three times per week for 20 minutes under various circumstances (e.g. "you had to exercise alone"; "you felt tired"). Respondents are asked to rate items on a scale from 1, (not at all confident), to 10 (extremely confident).
Baseline, 3 weeks, 6 weeks
Physical Activity Partner Investment Scale
Time Frame: Baseline, 3 weeks, 6 weeks
The Physical Activity Partner Investment Scale assesses the degree to which the partner in a couple defines the patient engaging in regular physical activity as a shared responsibility as well as the degree to which they are taking action to address barriers to the patient engaging in physical activity . The 9 items selected were modified to be specific to engaging in regular physical activity. Participants are asked to rate their agreement each item on a scale from 1 (strongly disagree) to 7 (strongly agree). Example items include "If/when my partner decides to engage in regular physical activity , the responsibility will be his or hers alone.", "My partner and I are able to have useful discussions about how to engage in regular physical activity ." and "In the long run, my partner and I are able to work together toward helping one or both of us maintain a regular physical activity routine".
Baseline, 3 weeks, 6 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jennalee S Wooldridge, MA, University of Colorado, Denver

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

October 1, 2015

Primary Completion (ACTUAL)

September 1, 2017

Study Completion (ACTUAL)

February 1, 2018

Study Registration Dates

First Submitted

October 9, 2015

First Submitted That Met QC Criteria

October 15, 2015

First Posted (ESTIMATE)

October 19, 2015

Study Record Updates

Last Update Posted (ACTUAL)

March 21, 2018

Last Update Submitted That Met QC Criteria

March 19, 2018

Last Verified

March 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • 15-0601

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Collaborative Implementation Intentions

Clinical Trials on Control

Subscribe